Shares of Anthera Pharmaceuticals, Inc. (OTCMKTS:ANTH – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.00. Anthera Pharmaceuticals shares last traded at $0.00, with a volume of 40,000 shares changing hands.
Anthera Pharmaceuticals Stock Up -50.0 %
Anthera Pharmaceuticals Company Profile
Anthera Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy.
Read More
- Five stocks we like better than Anthera Pharmaceuticals
- Canadian Penny Stocks: Can They Make You Rich?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- Manufacturing Stocks Investing
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
- Most Volatile Stocks, What Investors Need to Know
- 3 Stocks With Rising Prices That Are Likely to Split in 2025
Receive News & Ratings for Anthera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
